Stocks
Editas Medicine (EDIT) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -141.1 | -134.8 | -193.1 | -226.0 | -163.1 | -177.2 | ||
| Changes by years, y/y, % | +24% | -4% | +43% | +17% | -28% | +7.5% | |||
Editas Medicine. EBITDA US GAAP, bln rub
Editas Medicine. EBITDA US GAAP, changes, %
Editas Medicine. EBITDA US GAAP, sum by quarters, bln rub
Editas Medicine (EDIT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -51.0 | -44.1 | -45.0 | -22.5 | -65.6 | -177.2 | |
| Changes by years, y/y, % | +4% | -16% | -19% | -65% | +29% | |||
| Changes by quarters, q/q, % | -20% | -13% | +2% | -50% | +192% | |||
